3 High-Yield Stocks with Major Growth Prospects

When it comes to income stocks, most investors know they won't become millionaires overnight. These types of stocks usually grow slowly, and it may take several years for investors to see substantial profits. This means only the most patient investors will actually see these stocks reaching their full potential over time.

But here is some good news for the more impatient income investors: Growth and rich yields are not mutually exclusive. On the contrary, it's not too difficult to find companies that combine strong growth prospects with yields that are much better than the typical stock in the S&P 500.

Here is how I go about identifying high-yielding growth stocks...

To find stocks offering equal parts income and growth, I ran a screen that included the following criteria: U.S. stocks yielding 4% or better and annual earnings per share (EPS) growth prospects of at least 15% in the next five years. This gave me a list of more than 20 names. I further refined the list by eliminating companies that haven't grown the dividend in the past five years.

Here are the winners…

1. Meridian Bioscience Inc. (Nasdaq: VIVO)
Yield: 4%
Estimated five-year annual EPS growth: 16%

Meridian has an industry-leading market share in diagnostic test kits used to identify and treat common gastrointestinal, viral and respiratory infections. The company sells its products and technologies to hospitals, laboratories, research centers and physician offices in more than 60 countries.

[More from StreetAuthority.com: ]

The major growth driver for Meridian is its new Illumigene line of molecular tests. The company introduced a test for diarrhea-causing bacteria last year and is introducing tests for neonatal infection, strep throat and whooping cough this year, all of which are expected to quadruple Illumigene's sales. In addition, sales of food-borne tests, which grew 30% last year, should accelerate this year as Meridian introduces a food-borne test for Campylobacter, the No.1 contaminant in poultry.

Meridian's sales rose 12% in fiscal year (Sept.) 2011 to $159.7 million, while earnings (excluding non-cash items) improved 6% to $0.69 per share. The company is forcasting at least 23% growth and full-year 2012 EPS in the $0.85 to $0.89 range.

Analysts say Meridian can deliver at least 16% a year in earnings growth for the next five years. The company has posted 19 straight years of dividend growth and has raised dividends an average of 22% a year for the past five years. Based on the current $0.76 annual dividend, Meridian shares yield 4.3%.

2. Watsco Inc. (NYSE: WSO)
Yield: 4%
Estimated five-year annual EPS growth: 18%